Market open

Galapagos/€GLPG

08:00

10:10

12:15

14:25

16:30

1D1W1MYTD1Y5YMAX

About Galapagos

Galapagos NV, abbreviated as GLPG on stock exchanges, is a global biotechnology firm specializing in the discovery and development of small molecule medicines. The company focuses on innovating treatments primarily in the fields of immunology and oncology. Founded in 1999, Galapagos operates out of its headquarters in Belgium and extends its reach across Europe and the United States, aiming to provide transformative therapies for significant unmet medical needs.

Ticker

€GLPG

Sector

Health Care

Trading on

AEX

Industry

Biotechnology

Headquarters

Mechelen, Belgium

Employees

1,123

Website

www.glpg.com

Galapagos Metrics

BasicAdvanced

€1.5B

7.51 €3.14

0.09 -

Price and volume

Market cap

€1.5B

Beta

0.09

52-week high

€31.08

52-week low

€22.00

Average daily volume

117K

Financial strength

Current ratio

10.134

Quick ratio

9.754

Long term debt to equity

0.253

Total debt to equity

0.401

Interest coverage (TTM)

-107.54%

Management effectiveness

Return on assets (TTM)

-2.38%

Return on equity (TTM)

-2.21%

Valuation

Price to earnings (TTM)

7.513

Price to revenue (TTM)

5.96

Price to book

0.54

Price to tangible book (TTM)

0.59

Price to free cash flow (TTM)

-3.764

Growth

Revenue change (TTM)

-52.19%

Earnings per share change (TTM)

-232.36%

3-year revenue growth (CAGR)

-18.13%

3-year earnings per share growth (CAGR)

4.98%

What the Analysts think about Galapagos

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Galapagos stock.

Galapagos Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

Galapagos Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Market data provided by CBOE Europe

Buy €GLPG

€

Capital at risk

Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Galapagos stock?

Galapagos (GLPG) has a market cap of €1.5B as of January 15, 2025.

What is the P/E ratio for Galapagos stock?

The price to earnings (P/E) ratio for Galapagos (GLPG) stock is 7.51 as of January 15, 2025.

Does Galapagos stock pay dividends?

No, Galapagos (GLPG) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Galapagos dividend payment date?

Galapagos (GLPG) stock does not pay dividends to its shareholders.

What is the beta indicator for Galapagos?

Galapagos (GLPG) has a beta rating of 0.09. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.